Clinical Trials Directory

Trials / Completed

CompletedNCT01435681

Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?

Can Short Latency Afferent Inhibition Give us Clues to Better Dystonia Treatments?

Status
Completed
Phase
Study type
Observational
Enrollment
5 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
10 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a research study using transcranial magnetic stimulation (TMS) to investigate interactions between the sensory system and the motor cortex in primary generalized dystonia (DYT1 dystonia) subjects who undergo deep brain stimulation (DBS) surgery. The sensory system is the body's sense organs - smell, sight, sound, etc. - and the motor cortex is the part of your brain where nerve impulses control voluntary muscle activity.

Detailed description

The cause of DYT1 dystonia is not clear. DYT1 dystonia symptoms include abnormal posture or repetitive twisting movements affecting one body part; in some patients, the entire body can twist and contort painfully. Magnetic resonance imaging (MRI) studies are normally used to evaluate changes in brain structure in DYT1 dystonia. Transcranial magnetic stimulation (TMS) is a painless, non-invasive method to test how your brain conducts electrical messages to the rest of your body, including your muscles. If you are a DYT1 dystonia patient, then this study involves up to three visits. The first visit (before DBS surgery) will last about 4 hours and the second and third visits (after DBS surgery) will last about 4 hours as well. These visits will include a complete physical and neurological exam, video recorded dystonia and mood rating scales, followed by electromyography (EMG) and TMS sessions. Subjects who have already undergone DBS surgery may participate in applicable visits based on the length of time since their DBS surgery. If you are a control subject, this study involves one visit, about 4 hours long. This visit will include TMS and EMG sessions.

Conditions

Timeline

Start date
2012-05-01
Primary completion
2014-10-01
Completion
2016-08-01
First posted
2011-09-19
Last updated
2016-09-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01435681. Inclusion in this directory is not an endorsement.